Arcutis Biotherapeutics, Inc. Profile Avatar - Palmy Investing

Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials …

Biotechnology
US, Westlake Village [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ARQT's Analysis
CIK: 1787306 CUSIP: 03969K108 ISIN: US03969K1088 LEI: - UEI: -
Secondary Listings
ARQT has no secondary listings inside our databases.